PDSB
Price
$1.24
Change
-$0.00 (-0.00%)
Updated
Aug 29 closing price
Capitalization
57.83M
74 days until earnings call
RXRX
Price
$4.70
Change
-$0.16 (-3.29%)
Updated
Aug 29 closing price
Capitalization
2.04B
67 days until earnings call
Interact to see
Advertisement

PDSB vs RXRX

Header iconPDSB vs RXRX Comparison
Open Charts PDSB vs RXRXBanner chart's image
PDS Biotechnology
Price$1.24
Change-$0.00 (-0.00%)
Volume$401.42K
Capitalization57.83M
Recursion Pharmaceuticals
Price$4.70
Change-$0.16 (-3.29%)
Volume$15.12M
Capitalization2.04B
PDSB vs RXRX Comparison Chart in %
Loading...
PDSB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PDSB vs. RXRX commentary
Aug 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PDSB is a Hold and RXRX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 30, 2025
Stock price -- (PDSB: $1.24 vs. RXRX: $4.70)
Brand notoriety: PDSB and RXRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PDSB: 79% vs. RXRX: 60%
Market capitalization -- PDSB: $57.83M vs. RXRX: $2.04B
PDSB [@Biotechnology] is valued at $57.83M. RXRX’s [@Biotechnology] market capitalization is $2.04B. The market cap for tickers in the [@Biotechnology] industry ranges from $100.25B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PDSB’s FA Score shows that 0 FA rating(s) are green whileRXRX’s FA Score has 1 green FA rating(s).

  • PDSB’s FA Score: 0 green, 5 red.
  • RXRX’s FA Score: 1 green, 4 red.
According to our system of comparison, both PDSB and RXRX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PDSB’s TA Score shows that 6 TA indicator(s) are bullish while RXRX’s TA Score has 4 bullish TA indicator(s).

  • PDSB’s TA Score: 6 bullish, 2 bearish.
  • RXRX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, PDSB is a better buy in the short-term than RXRX.

Price Growth

PDSB (@Biotechnology) experienced а +4.20% price change this week, while RXRX (@Biotechnology) price change was -4.86% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.70%. For the same industry, the average monthly price growth was +20.57%, and the average quarterly price growth was +29.45%.

Reported Earning Dates

PDSB is expected to report earnings on Nov 12, 2025.

RXRX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (-0.70% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RXRX($2.04B) has a higher market cap than PDSB($57.8M). PDSB YTD gains are higher at: -23.926 vs. RXRX (-30.473). PDSB has higher annual earnings (EBITDA): -32.36M vs. RXRX (-583.64M). RXRX has more cash in the bank: 525M vs. PDSB (31.9M). PDSB has less debt than RXRX: PDSB (18.5M) vs RXRX (88.1M). RXRX has higher revenues than PDSB: RXRX (64.5M) vs PDSB (0).
PDSBRXRXPDSB / RXRX
Capitalization57.8M2.04B3%
EBITDA-32.36M-583.64M6%
Gain YTD-23.926-30.47379%
P/E RatioN/AN/A-
Revenue064.5M-
Total Cash31.9M525M6%
Total Debt18.5M88.1M21%
FUNDAMENTALS RATINGS
PDSB: Fundamental Ratings
PDSB
OUTLOOK RATING
1..100
19
VALUATION
overvalued / fair valued / undervalued
1..100
36
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PDSBRXRX
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 6 days ago
86%
Bullish Trend 9 days ago
85%
Declines
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 2 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
88%
Aroon
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
PDSB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AABCX16.38N/A
N/A
Putnam Dynamic Asset Allocation Bal C
PSCRX15.96N/A
N/A
Putnam Small Cap Value R
FZAFX26.34N/A
N/A
Fidelity Advisor Equity Growth Z
VLAIX41.83N/A
N/A
Value Line Asset Allocation Instl
OCHIX9.38N/A
N/A
Oberweis China Opportunities Instl